TW200501959A - Antifungal agents - Google Patents
Antifungal agentsInfo
- Publication number
- TW200501959A TW200501959A TW093103652A TW93103652A TW200501959A TW 200501959 A TW200501959 A TW 200501959A TW 093103652 A TW093103652 A TW 093103652A TW 93103652 A TW93103652 A TW 93103652A TW 200501959 A TW200501959 A TW 200501959A
- Authority
- TW
- Taiwan
- Prior art keywords
- athlete
- foot
- chloride
- drug
- antifungal agents
- Prior art date
Links
- 229940121375 antifungal agent Drugs 0.000 title abstract 2
- 239000003429 antifungal agent Substances 0.000 title abstract 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 2
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 abstract 2
- 201000004647 tinea pedis Diseases 0.000 abstract 2
- MCCACAIVAXEFAL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 MCCACAIVAXEFAL-UHFFFAOYSA-N 0.000 abstract 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 abstract 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 abstract 1
- MQHLMHIZUIDKOO-AYHJJNSGSA-N amorolfine Chemical compound C1=CC(C(C)(C)CC)=CC=C1CC(C)CN1C[C@@H](C)O[C@@H](C)C1 MQHLMHIZUIDKOO-AYHJJNSGSA-N 0.000 abstract 1
- 229960005279 amorolfine hydrochloride Drugs 0.000 abstract 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 abstract 1
- 229960001950 benzethonium chloride Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 abstract 1
- 229960005040 miconazole nitrate Drugs 0.000 abstract 1
- 229950004864 olamine Drugs 0.000 abstract 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
- 229960004889 salicylic acid Drugs 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- FUSNMLFNXJSCDI-UHFFFAOYSA-N tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 abstract 1
- 229960004880 tolnaftate Drugs 0.000 abstract 1
- 229940043810 zinc pyrithione Drugs 0.000 abstract 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 abstract 1
- 229930007845 β-thujaplicin Natural products 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
This invention relates to an antifungal agent containing amorolfine hydrochloride together with at least one member selected from the following components: miconazole nitrate, ciclopriox olamine, tolnaftate, salicylic acid, chlorhexidine hydrochloride, benzethonium chloride, decalinium chloride, hinokitiol and zinc pyrithione. Compared with the case of used alone, individual components exert synergistic effects on the fungus causative of athlete's foot. Thus, the above agent is useful as a drug for athlete's foot on which satisfactory therapeutic effects can be hardly exerted hitherto because of interruption in continuous drug application before complete cure.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003043130 | 2003-02-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200501959A true TW200501959A (en) | 2005-01-16 |
Family
ID=32905389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093103652A TW200501959A (en) | 2003-02-20 | 2004-02-16 | Antifungal agents |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP4730094B2 (en) |
| TW (1) | TW200501959A (en) |
| WO (1) | WO2004073715A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4783010B2 (en) * | 2004-12-20 | 2011-09-28 | 肇一 柴 | Antifungal |
| JP2007084496A (en) * | 2005-09-22 | 2007-04-05 | Nippon Nohyaku Co Ltd | Antifungal agent composition |
| KR101899413B1 (en) * | 2018-05-03 | 2018-09-18 | 주식회사 케어사이드 | Composition for prevention and treatment of skin infection |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2208598A (en) * | 1987-08-15 | 1989-04-12 | Ciba Geigy Ag | Antimicrobial preparations for external use |
| WO1993017559A1 (en) * | 1992-03-13 | 1993-09-16 | Otsuka Pharmaceutical Co., Ltd. | Method of treating infectious disease, method of preventing putrefaction of cosmetic, and antibacterial/antifungal agent and cosmetic |
| JP3941132B2 (en) * | 1995-06-07 | 2007-07-04 | 大正製薬株式会社 | Antifungal |
| JPH09110693A (en) * | 1995-08-10 | 1997-04-28 | Taisho Pharmaceut Co Ltd | Antifungal agent |
| JP4227677B2 (en) * | 1996-12-10 | 2009-02-18 | 杏林製薬株式会社 | Film-forming antifungal composition |
| US6231875B1 (en) * | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
| JP2002363101A (en) * | 2001-04-03 | 2002-12-18 | Taisho Pharmaceut Co Ltd | Preparation for external use |
| JP4081312B2 (en) * | 2002-06-28 | 2008-04-23 | 佐藤製薬株式会社 | Antifungal agent for external use |
-
2004
- 2004-02-16 TW TW093103652A patent/TW200501959A/en unknown
- 2004-02-19 WO PCT/JP2004/001892 patent/WO2004073715A1/en active Application Filing
- 2004-02-19 JP JP2005502765A patent/JP4730094B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2004073715A1 (en) | 2006-06-01 |
| JP4730094B2 (en) | 2011-07-20 |
| WO2004073715A1 (en) | 2004-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0225474D0 (en) | Therapeutic agents | |
| BR0317564A (en) | Compounds, compositions and methods for treating bacterial or fungal diseases | |
| RS20050888A (en) | Fungicidal mixtures for controlling rice pathogen s | |
| GB0223038D0 (en) | Therapeutic compounds | |
| BR0312479A (en) | Hair and / or scalp treatment composition, dandruff treatment method and use of basil oil | |
| DE50211758D1 (en) | COSMETIC PREPARATIONS CONTAINING POLYHEXAMETHHYLENE BIGUANIDE HYDROCHLORIDE AND DISTEARYLDIMETHYLAMMONIUM CHLORIDE | |
| WO2004089396A3 (en) | Anti-fungal peptidomimetics | |
| BR0209020A (en) | Polyallylamine Pharmaceutical Composition | |
| DE60335057D1 (en) | Cosmetic primer containing a combination of antiperspirant and antimicrobial agents | |
| BR0316085A (en) | Microbicidal substances | |
| NO982775D0 (en) | Composition containing a fungicide and a sulfur mixture | |
| WO2004110151A8 (en) | Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments | |
| UA90755C2 (en) | Fungicidal mixture, agent based thereon, method for controlling phytopathogenic fungi and seed | |
| TW200501959A (en) | Antifungal agents | |
| BR0316086A (en) | N-sulfonyl-4-methylene amino-3-hydroxy-2-pyridones as a microbicidal agent | |
| BR0312963A (en) | Durable Antimicrobial Leather | |
| ATE260559T1 (en) | SORDARINE DERIVATIVES | |
| DE69813833D1 (en) | 4-Cyano-4-DEFORMYLSORDARIZIN DERIVATIVES | |
| UA90340C2 (en) | Fungicidal mixture based on triazoles, composition based thereon and method for controlling phytopatogenic fungi | |
| DE69815355D1 (en) | 4-cyano-4-DEFORMYLSORDARINDERIVATE | |
| PT1603559E (en) | Pharmaceutical composition for intracellular acidification with cis-urocanic acid | |
| EP1585732A4 (en) | Spermicidal and/or antifungal composition and methods of using the same | |
| PT1233748E (en) | ASSOCIATION OF RETINAL AND ALDEIDS WITH ANTIFUNGAL ACTIVITY | |
| DK1524906T3 (en) | Fungicidal mixtures | |
| WO2005032249A3 (en) | Fungicidal mixtures based on a triazolopyrimidine derivative and a conazole |